China and India are the only two major countries that have been willing to export vaccines while also vaccinating their own people. Meanwhile, to rich countries, the billions of dollars of vaccine market for Big Pharma far outweigh the benefits of saving millions of lives
The COVID-19 pandemic demands that all nations cooperate to vaccinate the entire global population. The usual rules of which countries win and which ones lose do not operate in this civilizational crisis
The recent regulatory clearance given to an indigenous developed vaccine candidate in India is an example of vaccine nationalism at its worst and jettisoning of all the principles of an evidence-based, scientific approach
India’s mass vaccination plans may fail if it does not hold open discussions on its plans with health professionals and the people
As trials for vaccine candidates continue, the question of which countries will gain access to it has become pressing. Low-income countries are likely to suffer in this regard
Newsclick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss the challenges of taking a vaccine to the people in countries like India. They also look at the various vaccine candidates in contention
Even if the major economies can solve their own problems of procuring the vaccines by jumping the queue with money or captive production capacities, what about the rest of the world?
Having surrendered before the epidemic, India’s Narendra Modi govt. is hoping that the economy will bail it out. Unfortunately, we are likely to face the worst of both: a worsening epidemic and an economy that continues to shrink